Neoleukin Therapeutics In... (NLTX)
NASDAQ: NLTX
· Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 9:00 PM
Neoleukin Therapeutics Revenue
Neoleukin Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending September 30, 2023, Neoleukin Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
7
Market Cap
8.2M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|